Related Experiment Video
Updated: Aug 4, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Targeting treatments to special populations
1University of Minnesota, Department of Psychiatry, Minneapolis 55455, USA. hatsu001@tc.umn.edu
Summary
Tailoring tobacco cessation treatments to specific populations, such as by gender, age, or administration route, may improve long-term abstinence rates beyond the current 25% average. Addressing unique needs can enhance treatment success.
Area of Science:
- Public Health
- Addiction Medicine
- Behavioral Science
Background:
- Long-term tobacco abstinence rates in treatment-seeking individuals average 25%.
- Current tobacco cessation treatments often employ generic approaches.
- Tobacco users represent a heterogeneous population with potentially diverse treatment needs.
Purpose of the Study:
- To review treatment issues for special populations of tobacco users.
- To examine specific needs based on gender, age, and route of tobacco administration.
- To identify research gaps and future directions for tailored cessation interventions.
Main Methods:
- Literature review of tobacco cessation strategies.
- Analysis of treatment considerations for distinct demographic and usage groups.
- Discussion of scientific literature gaps.
Main Results:
- Special populations may have unique tobacco cessation requirements.
- Generic approaches may not be optimal for all individuals.
- Tailored interventions have the potential to increase treatment success.
Conclusions:
- Identifying population-specific needs is crucial for effective tobacco cessation.
- Future research should focus on developing and evaluating tailored treatments.
- Addressing diverse needs can augment long-term tobacco abstinence rates.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.